WASHINGTON, DC—U.S. Department of Health and Human Services Secretary Tommy G. Thompson announced at the beginning of the month that retired Maj. Gen. Philip K. Russell, M.D., the founding president of the Albert B. Sabin Vaccine Institute will join the department as a special advisor on vaccine development and production. Russell is an expert on virology who was Commander of the U.S. Army Medical Research and Development Command.
WASHINGTON, DC— The Sabin Vaccine Institute Board of Trustees voted at its fall meeting to appoint two new board members, U.S. legislative advisor Mary Ann Chaffee and development expert Nancy Gardner Hargrave.
(NEW CANAAN, CT)—A scientist on the verge of a major laboratory eakthrough in creating a vaccine against a parasite that has devastated populations in India and China goes looking for funding to continue his work—but finds “zero interest” from pharmaceutical companies, large and small.
The collision between a Chinese F-8 fighter and an American Navy EP-3 electronic reconnaissance plane over the tropical island of Hainan threatens to cast a Cold War-style shadow over diplomatic relations between China and the Bush administration.
Arlington, Virginia – John B. Robbins, who played central roles in the development of vaccines to prevent Haemophilus Influenzae B (Hib), a leading cause of meningitis, and pertussis, has been chosen as the ninth recipient of the Albert Sabin Gold Medal. The Albert B. Sabin Vaccine Institute awards the medal annually to an exemplary contributor to disease prevention.